Dysfunction Prevalence (%) Erectile dysfunction 20–90 Climacturia 14–28 Arousal incontinence 93 Orgasmic dysfunction (anorgasmia, delayed orgasm, dysorgasmia, decreased orgasm intensity) 18–46 Reduced penile size 68–71 Peyronie’s disease 16 The significant…
Fig. 6.1 An illustration of how traditional approaches to pelvic floor dysfunctions have been segmented according to disciplines and pelvic compartments There is a common agreement that many problems or…
Nomogram (PLND type) used to derive % risk of finding positive LNs at RP Low risk patient: cT1c, PSA 2.5, Gleason 3 + 3, 3/12 positive cores (%) Intermed. Risk patient :…
The key players and their involvements are displayed below. Items which concern mainly preoperative care are highlighted in green. Items which concern mainly intra-operative care are highlighted in yellow. Items…
1. WG1, Handling of Radical Prostatectomy Specimens. R Montironi (Chair), H Samaratunga, L True 2. WG2, pT2 substaging and tumour volume in prostatectomy specimens. T Van der Kwast (Chair), M…
Fig. 7.1 Open retropubic radical prostatectomy: Incision of the prostatic apex Fig. 7.2 Prostatic bed after removal of the prostate 7.3 Radical Prostatectomy: Oncological Results Today there are several consolidated…
Risk classification Stage PSA Gleason Low risk T1-2a ≤10 ng/ml ≤6 Intermediated risk T2b >10 and ≤ 20 ng/ml 7 High risk T2c-3a >20 ng/ml ≥ 8 This system uses PSA level, Gleason grade, and…
Fig. 6.1 MR images of a 63-year-old patient with prostate-specific antigen (PSA) progression from 3.8 ng/mL (2012) to 4.9 ng/mL (2013). (a) High-resolution axial T2-weighted fast spin-echo image showing a focal hypointense…
Fig. 10.1 Proposed spiral model for prostate cancer progression by Logothetis [8] According to this model, the transition from endocrine to paracrine-driven prostate cancer is associated with a number of…
Parameter Value Age (years) 67.6 ± 8.5 (69), 46–76 Total PSA (ng/ml) 6.9 ± 23.2 (3.5), 0.003–146.0 Familiarity 24 (16.3) Gleason score ≤7(3 + 4) 115 (78) ≥7(4 + 3) 32 (22) Staging Localised 95 (65) Locally advanced…
